Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment.

Zhang D, Dong P, Zhang K, Deng L, Bach C, Chen W, Li F, Protzer U, Ding H, Zeng C.

BMC Microbiol. 2012 Dec 28;12:307. doi: 10.1186/1471-2180-12-307.

2.

Dynamic changes of HBV quasispecies and deletion patterns in a chronic hepatitis B patient.

Ji F, Zhou L, Ma S, Li F, Ding H, Zeng C.

J Med Virol. 2009 Sep;81(9):1551-9. doi: 10.1002/jmv.21595.

PMID:
19626620
3.

Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease.

Sugauchi F, Ohno T, Orito E, Sakugawa H, Ichida T, Komatsu M, Kuramitsu T, Ueda R, Miyakawa Y, Mizokami M.

J Med Virol. 2003 Aug;70(4):537-44.

PMID:
12794715
4.

Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.

Pollicino T, Amaddeo G, Restuccia A, Raffa G, Alibrandi A, Cutroneo G, Favaloro A, Maimone S, Squadrito G, Raimondo G.

Hepatology. 2012 Aug;56(2):434-43. doi: 10.1002/hep.25592. Epub 2012 Jul 13.

PMID:
22271491
5.

Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection.

Gerken G, Kremsdorf D, Capel F, Petit MA, Dauguet C, Manns MP, Meyer zum Büschenfelde KH, Brechot C.

Virology. 1991 Aug;183(2):555-65.

PMID:
1853561
6.

The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C.

Mun HS, Lee SA, Jee Y, Kim H, Park JH, Song BC, Yoon JH, Kim YJ, Lee HS, Hyun JW, Hwang ES, Kook YH, Kim BJ.

J Med Virol. 2008 Jul;80(7):1189-94. doi: 10.1002/jmv.21208.

PMID:
18461612
7.

Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.

Ohkawa K, Takehara T, Kato M, Deguchi M, Kagita M, Hikita H, Sasakawa A, Kohga K, Uemura A, Sakamori R, Yamaguchi S, Miyagi T, Ishida H, Tatsumi T, Hayashi N.

J Infect Dis. 2008 Oct 15;198(8):1150-8. doi: 10.1086/591941.

8.

Full-length hepatitis B virus sequences from naïve patients with fluctuation of viral load during ADV monotherapy.

Li Y, Zhu M, Guo Y, Chen W, Li G.

Virus Genes. 2010 Apr;40(2):155-62. doi: 10.1007/s11262-009-0429-z. Epub 2009 Dec 12.

PMID:
20012680
9.

Gene heterogeneity of hepatitis B virus isolates from patients with severe hepatitis B.

Wu W, Chen Y, Ruan B, Li LJ.

Hepatobiliary Pancreat Dis Int. 2005 Nov;4(4):530-4.

10.

PreS deletion mutations of hepatitis B virus in chronically infected patients with simultaneous seropositivity for hepatitis-B surface antigen and anti-HBS antibodies.

Huang X, Qin Y, Zhang P, Tang G, Shi Q, Xu J, Qi F, Shen Q.

J Med Virol. 2010 Jan;82(1):23-31. doi: 10.1002/jmv.21669.

PMID:
19950231
12.

Full-length sequence and functional analysis of hepatitis B virus genome in a virus carrier: a case report suggesting the impact of pre-S and core promoter mutations on the progression of the disease.

Kajiya Y, Hamasaki K, Nakata K, Nakagawa Y, Miyazoe S, Takeda Y, Ohkubo K, Ichikawa T, Nakao K, Kato Y, Eguchi K.

J Viral Hepat. 2002 Mar;9(2):149-56.

PMID:
11876799
13.
14.

[The relation between virus genotypes and coexisting surface antigen and antibody in patients with hepatitis B, and the development of preS region deletions].

Yukimasa N, Matsuda R, Yasuhara T, Takagi Y, Gomi K.

Rinsho Byori. 2005 Aug;53(8):698-702. Japanese.

PMID:
16190354
15.

Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases.

Raimondo G, Costantino L, Caccamo G, Pollicino T, Squadrito G, Cacciola I, Brancatelli S.

J Hepatol. 2004 Mar;40(3):515-9.

PMID:
15123368
16.

Evolutionary pattern of full hepatitis B virus genome during sequential nucleos(t)ide analog therapy.

Tang YZ, Liu L, Pan MM, Wang YM, Deng GH.

Antiviral Res. 2011 Jun;90(3):116-25. doi: 10.1016/j.antiviral.2011.03.183. Epub 2011 Apr 1.

PMID:
21440005
17.

Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance.

Chen CH, Lee CM, Tung WC, Wang JH, Hung CH, Hu TH, Wang JC, Lu SN, Changchien CS.

J Hepatol. 2010 Apr;52(4):478-85. doi: 10.1016/j.jhep.2010.01.006. Epub 2010 Feb 2.

PMID:
20185198
18.

Replicating and virion secreting hepatitis B mutant virus unable to produce preS2 protein.

Fernholz D, Stemler M, Brunetto M, Bonino F, Will H.

J Hepatol. 1991;13 Suppl 4:S102-4.

PMID:
1822500
19.

PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.

Petit MA, Capel F, Zoulim F, Dubanchet S, Chemin I, Penna A, Ferrari C, Trépo C.

Arch Virol Suppl. 1992;4:105-12.

PMID:
1280500
20.

Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals.

Revill PA, Littlejohn M, Ayres A, Yuen L, Colledge D, Bartholomeusz A, Sasaduesz J, Lewin SR, Dore GJ, Matthews GV, Thio CL, Locarnini SA.

AIDS. 2007 Aug 20;21(13):1701-10.

PMID:
17690567
Items per page

Supplemental Content

Write to the Help Desk